非小细胞肺癌tnm分期的外科临床应用.pptVIP

非小细胞肺癌TNM分期的外科临床应用 张鹏 天津医科大学总医院心胸外科 Staging determines: Anatomic extent Treatment Prognosis Anatomic extent Stage Treatment Survival Prognosis Survival Stage Ⅰa (T1N0) 5-yr survival 65% Stage Ⅰb (T2N0) 40% Stage Ⅱa (T1N1) 35% Stage Ⅱb (T2N1, T3N0,) 25% Stage Ⅲa (T1-3N2, T3N1,) 10% Stage Ⅲb (T1-4N3, T4N0-3,) 5% Stage Ⅳ (M1) 1% NSCLC: clinical stage as a prognostic factor 肺癌的分期 C-TNM 临床分期（病史、查体 、影像学） P-TNM 病理分期 S-TNM